Shah Capital ends campaign against Novavax board after Sanofi deal
(Reuters) - Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors ...
10h ago
Kirin's electric spoon leaps from Ig Noble infamy to the dinner table
By Tom Bateman TOKYO (Reuters) - Japanese drinks giant Kirin Holdings will start selling an electrified spoon that researcher...
12h ago
S.Africa's top poultry producer flags bird flu risk amid vaccine delays
(Reuters) - South Africa remains at risk of bird flu due to delays in the roll-out of a broad vaccination programme, the coun...
14h ago
AstraZeneca plans to build $1.5 billion manufacturing facility in Singapore
(Reuters) -AstraZeneca said on Monday it plans to build a $1.5 billion manufacturing facility in Singapore in an effort to en...
16h ago
Genetic profile may predict best response to weight-loss drug Wegovy
By Nancy Lapid (Reuters) - Certain genes may identify patients with obesity who are most likely to respond strongly to Novo N...
17h ago
US race-neutral lung assessments to have profound effects, study finds
By Nancy Lapid (Reuters) - A guideline for U.S. doctors to ignore race in assessing lung health will likely have profound eff...
May 19, 2024
Bird flu found in western China as US combats cattle outbreak
BEIJING (Reuters) - Cases of bird flu have been confirmed among wild fowl in western China, the agriculture ministry said on ...
May 18, 2024
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
By Blake Brittain (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after...
May 17, 2024
J&J-backed startup Rapport files for US IPO
(Reuters) - Biopharmaceutical company Rapport Therapeutics, backed by the venture capital arm of Johnson & Johnson, filed...
May 17, 2024
Ontario reports first death from measles in over a decade
TORONTO, (Reuters) - An Ontario child under the age of five has died of measles making it the first such case in more than a ...
May 17, 2024